Aghazadeh Behzad
All 4 shown
- Scribe Therapeutics, Inc. Director, 10% owner, Other$144,266Open-market buy
- Scribe Therapeutics, Inc. Director, 10% owner, Other$1,115,500Open-market buy
- Scribe Therapeutics, Inc. Director, 10% owner, Other$34,999,995Open-market buy
- Scribe Therapeutics, Inc. Director, Other14,725 sharesGrant